Pharmacy News

Today's Pharmaceutical and Pharmacy News

Daily News Topic:

FDA News

5/19/12 - FDA approves Plavix as a generic [The Philadelphia Inquirer]

It had U.S. sales of about $6.7 billion for the 12 months ending March 31, 2012, according to IMS Health. Pittsburgh- based Mylan Pharmaceuticals was the first to file an application for generic approval so it will have six months as the only generic on the market. The FDA said Teva Pharmaceuticals, Dr. Reddy's Laboratories, Gate Pharmaceuticals an

5/19/12 - United States : DEVENS plant gets FDA approval [TendersInfo (India)]

Bristol-Myers Squibb Co. announced Tuesday that the Food and Drug Administration has sanctioned its Devens producing plant for manufacture of its rheumatoid arthritis drug Orencia. According to Bristol-Myers officials, approximately 300 scientists, engineers, quality specialists and additional staff work at the Devens plant, which started...

5/19/12 - United States : FDA grants approval to Mylan ANDA for Clopidogrel tablets [TendersInfo (India)]

Mylan Pharmaceuticals' abbreviated new drug application for Clopidogrel tablets USP, 75 mg and 300 mg has secured FDA approval. Sanofi-Aventis' Plavix's generic version is indicated for acute coronary syndrome and for patients with a latest history of myocardial infarction, stroke or established peripheral arterial disease. Supply of this product w

5/19/12 - United States : Glenmark Generics gets US FDA s tentative approval for zolmitriptan [TendersInfo (India)]

Glenmark Generics Inc. USA, the US based subsidiary of Glenmark Generic, has obtained tentative approval from US FDA, for zolmitriptan orally disintegrating tablets. The zolmitriptan orally disintegrating tablets are the generic version of AstraZeneca s Zomig-ZMT Tablets. In September 2011, Glenmark obtained tentative approval for its immediate...

5/18/12 - A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to Help More Patients with Multiple Myeloma Says Tackle Cancer Foundation

Leaders of the Tackle Cancer Foundation said they are excited to learn that a new drug for patients with multiple myeloma, pomalidomide from CELGENE, has been submitted to the Food and Drug Administration. Don Wright, the 71- year-old marathon runner sponsored by TCF in the E-Race Cancer Campaign, takes pomalidomide for his multiple myeloma.

5/18/12 - Boston Scientific Announces FDA Approval of Stem Cell Drug; Osiris Receives Marketing Clearance for Prochymal

Below is a look at some of the headlines for companies that made news in the healthcare sector on May 17, 2012. Boston Scientific Corporation announces U.S. The Epic Stent is designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood fl

Chain Drug Review

Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.

Featured Article from Chain Drug Review:

AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more